AS Latvijas Juras medicinas centrs
AS Latvijas Juras medicinas centrs provides health care services in the Republic of Latvia. The company engages in the general and special medical practice, dental practice, human health, residential nursing care, residential care, social work, physical well-being, and other personal service activities. It also involved in provision of other education services related activities. In addition, the… Read more
AS Latvijas Juras medicinas centrs (UOM) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.075x
Based on the latest financial reports, AS Latvijas Juras medicinas centrs (UOM) has a cash flow conversion efficiency ratio of 0.075x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€474.45K) by net assets (€6.32 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
AS Latvijas Juras medicinas centrs - Cash Flow Conversion Efficiency Trend (2015–2024)
This chart illustrates how AS Latvijas Juras medicinas centrs's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
AS Latvijas Juras medicinas centrs Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of AS Latvijas Juras medicinas centrs ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
SOFINA (8FS.SG)
STU:8FS
|
N/A |
|
Gold Rock Holdings Inc
PINK:GRHI
|
2.618x |
|
ED Invest S.A.
WAR:EDI
|
0.089x |
|
Emerson Radio Corporation
NYSE MKT:MSN
|
-0.106x |
|
Glacier Lake Resources Inc
V:GLI
|
0.025x |
|
PLACE HOLDINGS SD -05
F:95N
|
N/A |
|
Divio Technologies AB Series B
ST:DIVIO-B
|
-0.114x |
|
Thai Ha Public Company Limited
BK:KASET
|
0.073x |
Annual Cash Flow Conversion Efficiency for AS Latvijas Juras medicinas centrs (2015–2024)
The table below shows the annual cash flow conversion efficiency of AS Latvijas Juras medicinas centrs from 2015 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | €6.38 Million | €625.34K | 0.098x | -68.23% |
| 2023-12-31 | €6.20 Million | €1.91 Million | 0.308x | +91.95% |
| 2022-12-31 | €6.81 Million | €1.09 Million | 0.161x | +143.58% |
| 2021-12-31 | €6.34 Million | €418.24K | 0.066x | -50.34% |
| 2020-12-31 | €5.52 Million | €732.71K | 0.133x | +77.02% |
| 2019-12-31 | €5.50 Million | €412.86K | 0.075x | -30.76% |
| 2018-12-31 | €5.53 Million | €599.57K | 0.108x | +34.95% |
| 2017-12-31 | €5.96 Million | €478.41K | 0.080x | +33.84% |
| 2016-12-31 | €6.97 Million | €418.49K | 0.060x | +17.88% |
| 2015-12-31 | €7.12 Million | €362.36K | 0.051x | -- |